[FURL=https://www.industryarc.com/Research/Methadone-Market-Research-507037?utm_source=freeprnow&utm_medium=Pressrelease&utm_campaign=Paidpressrelease]Methadone Market[/FURL] size is estimated to reach $105.3 million by 2026, growing at a CAGR of 4% over 2021-2026. Methadone is a medication that is used to treat chronic pain and is a synthetic narcotic analgesic which is part of a category called opioids. Methadone have a class of drugs known as opioid analgesics which is indicated for the management of pain in patients. Methadone has some affinity for the NMDA ionotropic glutamate receptor and also acts by binding to the µ-opioid receptor where the agonism of the µ-opioid receptors is used for the treatment of pain. Acute encephalopathy are detected in methadone intoxicated patients where brain MRI is helpful for the detection of methadone-induced encephalopathy. Growing prevalence of chronic diseases among people and rising incidence in opioid misuse are the major factors driving the growth of this market. Furthermore, increasing research and development activities regarding drugs is set to further enhance the overall market demand for Methadone Market for the period 2021-2026.
Key Takeaways
Geographically, in 2020, North America dominated the Methadone Market owing to growing incidence of drug addiction and higher adoption rate of opioid analgesics.
Growing prevalence of chronic disease and rising incidence in opioid misuse are likely to aid in the market growth of the Methadone.
Detailed analysis of the Strength, Weakness, and Opportunities of the prominent players operating in the market will be provided in the Methadone Market report.
Increasing side effects is set to create hurdles for the Methadone Market.
Request for Sample of the Report @ [FURL]https://www.industryarc.com/pdfdownload.php?id=507037[/FURL]
Methadone Segment Analysis – By Geography
North America dominated the Methadone Market with major share of 40% in 2020. This is owing to growing incidence of drug addiction and higher adoption rate of opioid analgesics. According to United Nation Office on Drug and Crime (UNODC) in 2017, more than 47,000 people have deaths owing to opioid overdose that increases the demand of methadone which acts as opioid receptors and are rising the growth of this market. However, Asia Pacific is estimated to outpace all the regions by clocking the highest CAGR of 2% during the forecast period 2021-2026 owing to rising population and increasing development in healthcare.
Methadone Market Drivers
Growing Prevalence of Chronic Disease
Rising Incidence in Opioid Misuse
Methadone top 10 companies include, Diskets, Methadoes, Aurolife Pharma LLC., Macfarlan Smith, VistaPharm, Qinghai Pharm, CentralPharm, Mallinckrodt, AIMS, and Roxane.
About IndustryARC: IndustryARC primarily focuses on Cutting Edge Technologies and Newer Applications market research. Our Custom Research Services are designed to provide insights on the constant flux in the global supply-demand gap of markets. Our strong team of analysts enables us to meet the client research needs at a rapid speed, with a variety of options for your business. Any other custom requirements can be discussed with our team, drop an e-mail to sales@industryarc.com to discuss more about our consulting services.